30 000 Lunette Cups to reach new customers in new channels
Peptonic Medical (publ) announced today that its wholly owned daughter company Lune Oy Ltd has signed a joint promotion agreement with American company Womanizer.
A strategic partnership between Womanizer and Lunette - two businesses on a mission to end taboos around masturbation and menstrual health - will see 30,000 Lunette Menstrual Cups reach new customers in new channels in March 2022.
In a continuation of an already flourishing relationship between the brands, and to mark International Women’s Day on the March 8, every purchaser of the bestselling Womanizer Premium Vibrator will receive Lunette Menstrual Cup for free. In the joint promotion program Womanizer will buy the products from Lune Oy Ltd at a discounted price.
This is not the first time Womanizer and Lunette have collaborated to highlight the close link between masturbation and menstrual wellbeing. Last year the brands worked together on a on a sizeable ‘mensturbation’ study that investigated the impact of masturbation on period pain. At the end of the research project, 70% of participants reported that masturbating had had a positive impact on the intensity of their period pains, whilst 90% said they would recommend masturbation as pain relief to a friend.
The cooperation is an important step in line with the Peptonic strategy to broaden the Lunette brand from sustainable period products to also include sustainable sexual wellness. The partnership will open up a new and relevant channel for this strategy with receivers of sexual health products that the company will launch during 2022, It will also help to further cement Peptonic Group and its brands as a leading voice in over-all intimate health.
This disclosure contains information that PEPTONIC Medical AB is obliged to make public pursuant to the EU Market Abuse Regulation (EU nr 596/2014). The information was submitted for publication, through the agency of the contact person, on 07-01-2022 04:10 CET.
Erik Sundquist, CEO
Telefon: + 46 722 49 90 43
E-post: erik.sundquist@peptonicmedical.se
About Peptonic Medical AB
Peptonic Medical AB (publ) is an innovative medtech company that conducts research, development and sales of medical devices and lifestyle products in the field of women's health. Peptonic launched its first product, VagiVital®️ Active Gel against vaginal atrophy, in July 2018. In April 2021, VagiVital®️ Moisturizing V Cleanser, was launched, a moisturizing and preventive intimate wash. The company was founded in 2009 and the share has been traded on Spotlight (www.spotlightstockmarket.com) in Stockholm since 2014.
Since August 2020, Lune Group Oy Ltd. has been a wholly owned subsidiary of Peptonic Medical. The company was founded in 2005 with the purpose to lead a light-hearted menstrual revolution in positive spirit via patented menstrual cups. The company is now evolving into leading the way in sustainable, intimate well-being.
In October 2021, all assets of Israeli company Common Sense Ltd were acquired. Common Sense has developed unique and patented self-tests to accurately diagnose bacterial vaginosis and amniotic fluid leakage respectively.